Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$67.99 - $89.57 $1.33 Million - $1.75 Million
-19,495 Reduced 73.24%
7,123 $554,000
Q2 2022

Aug 15, 2022

SELL
$56.6 - $89.9 $509,569 - $809,369
-9,003 Reduced 25.27%
26,618 $1.87 Million
Q1 2022

May 10, 2022

SELL
$60.15 - $84.52 $232,058 - $326,078
-3,858 Reduced 9.77%
35,621 $2.96 Million
Q4 2021

Feb 07, 2022

BUY
$75.08 - $121.99 $75 - $121
1 Added 0.0%
39,479 $3.04 Million
Q3 2021

Oct 27, 2021

BUY
$116.17 - $194.55 $158,107 - $264,782
1,361 Added 3.57%
39,478 $4.58 Million
Q2 2021

Aug 10, 2021

SELL
$130.4 - $225.58 $346,994 - $600,268
-2,661 Reduced 6.53%
38,117 $8.49 Million
Q1 2021

May 10, 2021

SELL
$124.11 - $190.17 $10.6 Million - $16.3 Million
-85,745 Reduced 67.77%
40,778 $5.22 Million
Q4 2020

Feb 11, 2021

SELL
$112.16 - $174.14 $8.01 Million - $12.4 Million
-71,448 Reduced 36.09%
126,523 $21.9 Million
Q3 2020

Nov 10, 2020

BUY
$58.05 - $111.31 $900,936 - $1.73 Million
15,520 Added 8.51%
197,971 $20.4 Million
Q2 2020

Aug 10, 2020

BUY
$57.2 - $74.41 $1.93 Million - $2.51 Million
33,734 Added 22.68%
182,451 $10.2 Million
Q1 2020

May 20, 2020

BUY
$57.05 - $95.75 $6.39 Million - $10.7 Million
112,046 Added 305.54%
148,717 $9.73 Million
Q4 2019

Feb 18, 2020

SELL
$68.3 - $93.8 $16,323 - $22,418
-239 Reduced 0.65%
36,671 $3.07 Million
Q3 2019

Nov 18, 2019

BUY
$61.86 - $97.8 $2.28 Million - $3.61 Million
36,910 New
36,910 $2.63 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.15B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.